The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
Also: Medisafe lands $30 million in a round led by Sanofi and January AI rakes in $8.8 million for glycemic response tool.
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
Panelists from DTx West share how they successfully executed a digital therapeutic and payer relationship.
Respiray’s wearable device allegedly kills over 99% of viruses and bacteria with UV light and filter.
Panelists at this morning's DTx West discuss how governments worldwide are looking at digital therapeutics.
In a recent study funded and coauthored by the company, the EaseVRx program outperformed a non-interactive headset app across several self-reported pain and pain-interference measures.
Medication delivery is currently available in metro areas of New York City, Chicago, Minneapolis, Boston and Austin.
The process aims to ensure tools meet NHS standards.
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients.
